Goldstein: Expect More Litigation After Myriad

June 13 (Bloomberg Law) -- Tom Goldstein, partner at Goldstein & Russell, PC and founder of SCOTUSblog, talks with Bloomberg Law's Lee Pacchia about the United States Supreme Court's decision in the Association for Molecular Pathology v. Myriad Genetics, Inc. case. At issue was whether patents may be granted on parts of the human body. He also explores whether Justice Scalia's concurrence raises doubts whether he believes in molecular biology, and where patent litigation will head in the wake of the decision. Bloomberg Law is a sponsor of SCOTUSblog.
The Ball Is in Tsipras’ Court: Asimakopoulou
57:39 - New Democracy Party Member of Parliament Anna Asimakopoulou discusses the results of the referendum in Greece and the politics behind it. She speaks on Bloomberg Television's “Market Makers.” (Source: Bloomberg)
  • What If Greek Banks Don't Open for Two Weeks?
  • Gold Poised to Break Three-Day Losing Streak
  • The Top 5 Business News Stories to Watch for Today